Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Thyroid Hormones
100%
Integrin
72%
Myeloproliferative Neoplasms
65%
Venous Thromboembolism
63%
Anticoagulation
58%
Thrombosis
52%
Myelofibrosis
47%
Israel
47%
Anemia
46%
Direct Oral Anticoagulants
43%
Polycythemia Vera
42%
Ovarian Cancer
39%
Low Molecular Weight Heparin
39%
Anticoagulants
36%
Israeli
35%
Platelets
32%
Chronic Myeloid Leukemia
32%
Hazard Ratio
32%
95% Confidence Interval
31%
Essential Thrombocythemia
30%
Bleeding
28%
High-grade Serous Ovarian Cancer (HGSOC)
27%
Major Bleeding
27%
OVCAR-3
26%
Ruxolitinib
26%
Tranexamic Acid
26%
Total Knee Replacement
26%
Antiphospholipid Syndrome
26%
Clinical Outcomes
25%
Venous Thrombosis
24%
Thrombophilia
23%
Atrial Fibrillation
23%
Vena Cava Filters
23%
COVID-19
22%
Clinical Significance
22%
Pulmonary Embolism
22%
Tyrosine Kinase Inhibitor
22%
Transfusion
22%
Hemophagocytic Lymphohistiocytosis
22%
Blood Storage
21%
Myeloma Cells
21%
Vitamin K Antagonists
21%
Warfarin
21%
Red Cells
20%
Hematological Malignancies
20%
Red Blood Cell Transfusion
20%
Thrombotic Events
20%
Splanchnic Vein Thrombosis
20%
Enoxaparin
19%
Activated Prothrombin Complex Concentrates (aPCC)
19%
Medicine and Dentistry
Venous Thromboembolism
72%
Thyroid Hormone
66%
Anticoagulation
61%
Thrombosis
60%
Myeloproliferative Neoplasm
57%
Integrin
55%
Malignant Neoplasm
51%
Diseases
44%
Myelofibrosis
44%
Anemia
38%
Antithrombotic
33%
Bleeding
33%
Polycythemia vera
32%
Retrospective Study
29%
Hazard Ratio
29%
Phlebothrombosis
29%
Direct Oral Anticoagulant
28%
Major Bleeding
28%
COVID-19
27%
Ovarian Cancer
27%
Antiphospholipid Syndrome
26%
Venae cavae
26%
Oral
25%
Inferior Vena Cava Filter
25%
Platelet
25%
Thromboembolism
24%
Prevalence
23%
Hematologic Malignancy
22%
Internal Medicine
22%
Ruxolitinib
20%
Low Molecular Weight Heparin
20%
Recurrent Disease
20%
Tranexamic Acid
19%
Total Knee Arthroplasty
19%
Myeloma Cell
19%
Pulmonary Embolism
19%
Thrombocytosis
19%
Infection
17%
B-Cell Chronic Lymphocytic Leukemia
17%
Deep Vein Thrombosis
16%
Multiple Myeloma
16%
Odds Ratio
15%
Hydroxyurea
15%
Cell Line
15%
Hemoglobins
14%
Blood Storage
14%
Blood Clotting Factor 10a Inhibitor
14%
Hemophagocytic Syndrome
14%
Hemostat
14%
Hematoma
14%